Related Experiment Videos
[Itraconazole action on Toxoplasma gondii]
L M Jamra1, V Amato Neto, L M Braz
1Setor de Toxoplasmose, Instituto de Medicina Tropical de São Paulo.
Revista Do Hospital Das Clinicas
|January 1, 1992
Summary
Itraconazole, an antifungal, showed no significant activity against Toxoplasma gondii in this study. This contrasts with prior findings on its effectiveness against Trypanosoma cruzi.
Area of Science:
- Antimicrobial drug discovery
- Parasitology
- Medicinal chemistry
Context:
- Toxoplasmosis is a significant parasitic infection with limited therapeutic options.
- Itraconazole is a triazolic antifungal agent with a known spectrum of activity.
- Previous research indicated itraconazole's efficacy against Trypanosoma cruzi.
Purpose:
- To evaluate the in vitro and in vivo activity of a novel triazolic derivative, itraconazole, against Toxoplasma gondii.
- To explore potential improvements in toxoplasmosis therapy regarding safety and dosing.
- To expand knowledge on the therapeutic spectrum of itraconazole.
Summary:
- This study investigated itraconazole's efficacy against Toxoplasma gondii using in vitro and in vivo mouse models.
- No significant anti-Toxoplasma gondii activity was observed for itraconazole.
- Results differed from previous findings demonstrating itraconazole's activity against Trypanosoma cruzi.
Impact:
- Highlights the need for targeted drug development for toxoplasmosis.
- Suggests itraconazole may not be a suitable candidate for treating Toxoplasma gondii infections.
- Underscores the importance of compound-specific activity within the triazolic class.